• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Uncharacterized protein C1orf86 (C1orf86)

ACP16239

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16239 Target NameFAAP20
Target SynonymsC1orf86; CA086_HUMAN; Chromosome 1 open reading frame 86; FAAP20; Fanconi anemia associated protein of 20 kDa; FP7162; RP11-181G12.3; Uncharacterized protein C1orf86FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-180
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6NZ36
Background Information
  • Uniprot Id

    Q6NZ36

  • Target Species

    Human

  • Target Name

    FAAP20

  • Target Full Name

    Fanconi anemia core complex-associated protein 20

  • Target Function

    Component of the Fanconi anemia (FA) complex required to recruit the FA complex to DNA interstrand cross-links (ICLs) and promote ICLs repair. Following DNA damage recognizes and binds 'Lys-63'-linked ubiquitin generated by RNF8 at ICLs and recruits other components of the FA complex. Promotes translesion synthesis via interaction with REV1.

  • Target Subcellular Location

    Nucleus. Chromosome.

  • Target Synonyms

    C1orf86; CA086_HUMAN; Chromosome 1 open reading frame 86; FAAP20; Fanconi anemia associated protein of 20 kDa; FP7162; RP11-181G12.3; Uncharacterized protein C1orf86

Inquire Recombinant Human Uncharacterized protein C1orf86 (C1orf86) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification